Table 2.

Effect of the intervention on HbA1C levels

	Baseline (n = 302)	Three-month (n = 268)		Three-month with baseline observation carried forward (n = 302)
	Diff (T-C)	Diff (T-C)	Diff-in-Diff	Diff (T-C)	Diff-in-Diff
	β adjusted	β adjusted	β adjusted	β adjusted	β adjusted
HbA1C	1.024*	0.415*	− 0.609**	0.439**	−0.481*

T-intervention group; C-control group; Diff (T-C) and Diff-in-Diff estimator controlled for covariates (sex, age, educational level, nutritional status body mass index, time since diagnosis and type of pharmacological treatment) and the baseline treatment modification

*p < 0.05; **p < 0.01